161 related articles for article (PubMed ID: 3522816)
1. Hypertension in black patients. Epidemiologic and pathophysiologic considerations.
Wallin JD
J Clin Hypertens; 1986 Mar; 2(1):7-12. PubMed ID: 3522816
[TBL] [Abstract][Full Text] [Related]
2. Essential hypertension in black and white subjects. Hemodynamic findings and fluid volume state.
Messerli FH; DeCarvalho JG; Christie B; Frohlich ED
Am J Med; 1979 Jul; 67(1):27-31. PubMed ID: 463913
[TBL] [Abstract][Full Text] [Related]
3. Urinary kallikrein and plasma renin activity as determinants of renal blood flow. The influence of race and dietary sodium intake.
Levy SB; Lilley JJ; Frigon RP; Stone RA
J Clin Invest; 1977 Jul; 60(1):129-38. PubMed ID: 874078
[TBL] [Abstract][Full Text] [Related]
4. Pathophysiologic and pharmacotherapy considerations in the management of the black hypertensive patient.
Cook CA
Am Heart J; 1988 Jul; 116(1 Pt 2):288-95. PubMed ID: 2899388
[TBL] [Abstract][Full Text] [Related]
5. Use of diuretic agents in obese or black patients with systemic hypertension.
Messerli FH; Schmieder RE
Am J Cardiol; 1986 Jul; 58(2):11A-14A. PubMed ID: 3728340
[TBL] [Abstract][Full Text] [Related]
6. Race and hypertension. What is clinically relevant?
Rutledge DR
Drugs; 1994 Jun; 47(6):914-32. PubMed ID: 7521831
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic and cardiac adaptation in essential hypertension. Consequences for therapy.
Messerli FH
J Clin Hypertens; 1985 Mar; 1(1):3-14. PubMed ID: 2425059
[TBL] [Abstract][Full Text] [Related]
8. Pathophysiologic mechanisms in essential hypertension: a clue to the therapeutic approach.
Messerli FH
J Cardiovasc Pharmacol; 1984; 6 Suppl 6():S875-9. PubMed ID: 6084143
[TBL] [Abstract][Full Text] [Related]
9. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
Jamerson KA
Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
[TBL] [Abstract][Full Text] [Related]
10. Hypertension: racial differences.
Eisner GM
Am J Kidney Dis; 1990 Oct; 16(4 Suppl 1):35-40. PubMed ID: 2220799
[TBL] [Abstract][Full Text] [Related]
11. Hypertension in blacks.
Saunders E
Med Clin North Am; 1987 Sep; 71(5):1013-29. PubMed ID: 3306202
[TBL] [Abstract][Full Text] [Related]
12. Tailoring treatment to minority patients.
Saunders E
Am J Med; 1990 Mar; 88(3B):21S-23S. PubMed ID: 2180289
[TBL] [Abstract][Full Text] [Related]
13. Aldosterone and alterations of hypertension-related vascular function in African Americans.
Kotchen TA; Kotchen JM; Grim CE; Krishnaswami S; Kidambi S
Am J Hypertens; 2009 Mar; 22(3):319-24. PubMed ID: 19151694
[TBL] [Abstract][Full Text] [Related]
14. Racial analysis of the volume-renin relationship in human hypertension.
Mitas JA; Holle R; Levy SB; Stone RA
Arch Intern Med; 1979 Feb; 139(2):157-60. PubMed ID: 434969
[TBL] [Abstract][Full Text] [Related]
15. Hemodynamic differences between black patients and white patients with essential hypertension. State of the art lecture.
Frohlich ED
Hypertension; 1990 Jun; 15(6 Pt 2):675-80. PubMed ID: 2190919
[TBL] [Abstract][Full Text] [Related]
16. Profile of systemic hypertension in black patients.
Wright JT
Am J Cardiol; 1988 Jun; 61(16):41H-45H. PubMed ID: 3289350
[TBL] [Abstract][Full Text] [Related]
17. Pharmacologic management of systemic hypertension in blacks.
Weir MR; Saunders E
Am J Cardiol; 1988 Jun; 61(16):46H-52H. PubMed ID: 3289351
[TBL] [Abstract][Full Text] [Related]
18. [Hypertension in the Negro patient].
Timmers GJ; Schouten JA; ter Wee PM; Gans RO
Ned Tijdschr Geneeskd; 1999 Jan; 143(5):229-34. PubMed ID: 10086150
[TBL] [Abstract][Full Text] [Related]
19. The relative importance of genetic and environmental factors in hypertension in black subjects.
Aderounmu AF
Clin Exp Hypertens (1978); 1981; 3(4):597-621. PubMed ID: 6117430
[TBL] [Abstract][Full Text] [Related]
20. Hypertension in blacks: insights from Africa.
Rayner BL; Spence JD
J Hypertens; 2017 Feb; 35(2):234-239. PubMed ID: 27841780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
